drugset / Trial / NCT00765375

Safety and Efficacy of the Use of Botox on Acne

NCT00765375 ↗

Phase 2 Terminated 5 enrolled DeNova Research
NaSingle-groupDouble-blindTreatment

Summary

• To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2008-12

Outcome

Outcome not reported

Stopped: “Investigator decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum Neurotoxin Type A Protein / enzyme biologic — —

Indications